human cux1 cdna (Addgene inc)
Structured Review

Human Cux1 Cdna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cux1+cdna/pXJ42-p200+CUX1+(Plasmid+%23100813)/pm37117763-412-6-12
Average 93 stars, based on 5 article reviews
Images
1) Product Images from "Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence."
Article Title: Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence.
Journal: Nature aging
doi: 10.1038/s43587-022-00177-0
Figure Legend Snippet: Fig. 1 | Identification and characterization of fSNP rs1537371. a, EMSA using NE isolated from human ECs, showing allele-imbalanced gel shifting on 22 of the 24 candidate fSNPs identified by Reel-seq screening of the CDKN2A/B locus using NE isolated from human PBMCs. Data for EMSA represent n = 3 biologically independent experiments. SNPs in red indicate no allele-imbalanced gel shifting. b, Genomic view of the 200-kb CDKN2A/B region showing the following tracks, ordered from top to bottom based on the ENCODE database. (1) SNP track showing locations of the 24 candidate fSNPs; (2–4) three epigenetic tracks for H3K27ac, H3K4me1 and H3K4me3, known as transcriptional factor-binding sites; (5) DNase I hypersensitivity sites (DNase I HS) in human astrocytes; (6) predicted regulatory elements including promoters (red) and enhancers (gray); (7) annotated genes including p14ARF, p16INK4a, p15INK4b and ANRIL. c, Zoomed-in view of the 4-kb genomic region around fSNP rs1537371, showing the same tracks as above plus the negative result from CUX1 ChIP–seq assay in three human cell lines, GM12878, K562 and MCF-7. d,e, Demonstration of fSNP rs1537371 by EMSA (d) and luciferase reporter assay (e). A, risk allele; C, nonrisk allele; T, very rare allele; RLA, relative luciferase activity. Data for EMSA represent n = 3 biologically independent experiments; data for luciferase reporter assays represent n = 6 biologically independent samples. f, Sequences showing mutations around rs1537371 in three independent CRISPR–cas9 clones (nos. 2, 19 and 56), together with wild-type sequence. CON, wild-type control. g, qPCR showing decreased expression of p16INK4a, one of the potential risk genes in the three mutants. Data for qPCR analysis represent n = 3 biologically independent samples, each performed in duplicate. h, Dot plot of fSNP rs1537371 and p16INK4a mRNA levels showing significantly higher expression of p16INK4a in healthy PBMCs carrying homozygous risk allele A/A versus nonrisk allele C/C (P = 0.047, n = 26). P values were calculated using two-tailed Student’s t-test, and all data are presented as mean ± standard error (s.e.). h, Non-normally distributed data related to quantification of p16INK4a expression are presented as median ± interquartile range, and P values were calculated with the nonparametric Mann–Whitney test for pairwise comparisons.
Techniques Used: Isolation, Binding Assay, ChIP-sequencing, Luciferase, Reporter Assay, Activity Assay, CRISPR, Clone Assay, Sequencing, Control, Expressing, Two Tailed Test, MANN-WHITNEY
Figure Legend Snippet: Fig. 2 | The role of CUX1 in regulation of p14ARF, p15INK4b, p16INK4a and ANRIL expression via binding to fSNP rs1537371. a, ChIP assay demonstrating reduced binding of CUX1 to a DNA fragment containing rs1537371 in CUX1 shRNA knockdown ECs (left), and no specific binding of CUX1 to two randomly selected DNA fragments as controls (con; right). CUX1-Ab, anti-CUX1 antibody; IgG-Ab, anti-IgG antibody as an isotype control; NS, not significant. Data for ChIP assay represent n = 3 biologically independent experiments. b, Sequencing analysis showing significant enrichment of the A allele versus the C allele in ChIP DNA compared to input DNA (n = 3), with P = 0.010. c, AIDP–Wb demonstrating specific binding of CUX1 to rs1537371, with risk allele A binding more CUX1 than nonrisk allele C. T is a very rare allele. Data for AIDP–Wb represent n = 3 biologically independent experiments. d, CUX1-dependent luciferase reporter assay in 293T cells showing luciferase activity in CUX1 shRNA knockdown (left) and CUX1-overexpressed ECs (right). pLVX-CUX1, CUX1 expression vector; rs1537371-A, luciferase reporter construct pGL3 (basic promoter vector, Promega); con, negative control. Data for this assay represent n = 6 biologically independent samples. e, qPCR (left) and immunoblot (right) showing downregulation of CUX1 in human ECs by shRNA knockdown. α-Tubulin was used as a loading control. Data for qPCR analysis represent n = 4 biologically independent samples, each performed in triplicate. Data for immunoblot analysis represent n = 3 biologically independent experiments. f, qPCR showing downregulation of p14ARF, p15INK4b, p16INK4a and ANRIL expression in CUX1 shRNA knockdown human ECs. Data for qPCR analysis represent n = 4 biologically independent samples, each performed in triplicate. g, Immunoblot analysis showing downregulation of p14ARF, p15INK4b and p16INK4a expression in CUX1 shRNA knockdown human ECs. Data for immunoblot analysis represent n = 3 biologically independent experiments. P values were calculated using two-tailed Student’s t-test, and all data are presented as mean ± s.e.).
Techniques Used: Expressing, Binding Assay, shRNA, Knockdown, Control, Sequencing, Luciferase, Reporter Assay, Activity Assay, Plasmid Preparation, Construct, Negative Control, Western Blot, Two Tailed Test
Figure Legend Snippet: Fig. 6 | Elevated CUX1 and p16INK4a expression in plaque zones from patients with carotid artery disease. a,b, qPCR showing significant increase in expression of CUX1 (P = 0.036) (a) and p16INK4a (P = 0.011) (b) in plaque versus normal-appearing zones obtained from patients with carotid artery atherosclerosis. Data for qPCR analysis represent n = 11 plaque zones and n = 9 normal-appearing zones. c,d, Nonparametric Spearman correlation analysis (c) and trend analysis (d) showing significant correlation between the expression levels of CUX1 and p16INK4a (P = 0.047 and P = 0.005, respectively; n = 13). e, Immunocytochemical staining with antibodies specifically against CUX1 (green) and p16INK4a (red) in plaque and normal-appearing zones from patients with carotid artery atherosclerosis. Data were generated by staining of n = 8 plaque zone and n = 8 normal-appearing zones in two independent experiments. DAPI (blue) was applied to stain fixed cells. f, Statistical analysis of immunocytochemical staining showing significant induction of CUX1 (P = 0.0025) and p16INK4a (P = 0.0006) in plaque zones compared to normal-appearing zones. g, qPCR showing a trend of increase with no statistical significance in the expression of SASP genes IL-6 (left; P = 0.502), IL-1β (middle; P = 0.255) and ICAM1 (right; P = 0.17). Data for qPCR analysis represent n = 11 plaque zones and n = 9 normal-appearing zones. a–d,g, Data presented as mean ± s.e. P values were calculated using two-tailed Student’s t-test. f, Non-normally distributed data are presented as median ± interquartile range, and P values were calculated with the nonparametric Mann–Whitney test.
Techniques Used: Expressing, Staining, Generated, Two Tailed Test, MANN-WHITNEY
Figure Legend Snippet: Fig. 7 | Demonstration that CUX1 regulates replicative senescence independently of p53 expression. a, Immunoblot analysis showing passage- dependent induction of p53 expression in p10 compared to p5 ECs. qPCR analysis showing that induction of p53 was not at the transcriptional level. b, Immunoblot (left) and qPCR analysis (right) showing no significant change in p53 expression following shRNA-mediated CUX1 knockdown in p10 ECs. c,d, Immunoblot and qPCR analysis showing no significant change in CUX1 expression (d) after p53 siRNA-mediated knockdown (c) in human ECs. e,f, SA-β-gal (e) and γ-H2AX (f) staining showing no significant change in EC senescence by comparison of scrambled siRNA control ECs with p53 siRNA knockdown ECs. Data for immunoblot analysis represent n = 3 biologically independent experiments; data for qPCR analysis represent n = 3 biologically independent samples, each performed in duplicate. Data for SA-β-gal and γ-H2AX staining represent n = 3 biologically independent experiments. P values were calculated using two-tailed Student’s t-test, and all data are presented as mean ± s.e.).
Techniques Used: Expressing, Western Blot, shRNA, Knockdown, Staining, Comparison, Control, Two Tailed Test
Figure Legend Snippet: Fig. 8 | Models highlighting the role of CUX1 in mediation of cellular senescence by activation of p16INK4a expression. a, The mechanism underlying the contribution of atherosclerosis-associated fSNP rs1537371 to susceptibility to age-related disease. Increased binding of CUX1 to the A allele (risk allele) versus the C allele (nonrisk allele) resulted in a higher level of p16INK4a expression which, in turn, augments senescence. b, The mechanism underlying the contribution of the CUX1/p16INK4a pathway to cellular senescence. Increased expression of CUX1 in response to telomere shortening, DNA damage and oxidative stress resulted in upregulated expression of p16INK4a and induction of cellular senescence.
Techniques Used: Activation Assay, Expressing, Binding Assay
Related Articles
Over Expression:Article Title: Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence Article Snippet: .. For overexpression of human CUX1 p200, Article Title: Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence. Article Snippet: .. For overexpression of human CUX1 p200, Clone Assay:Article Title: Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence Article Snippet: .. For overexpression of human CUX1 p200, Article Title: Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence. Article Snippet: .. For overexpression of human CUX1 p200, Expressing:Article Title: Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence Article Snippet: .. For overexpression of human CUX1 p200, Article Title: Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence. Article Snippet: .. For overexpression of human CUX1 p200, Plasmid Preparation:Article Title: Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence Article Snippet: .. For overexpression of human CUX1 p200, Article Title: Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence. Article Snippet: .. For overexpression of human CUX1 p200, Sequencing:Article Title: Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence Article Snippet: .. For overexpression of human CUX1 p200, Article Title: Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence. Article Snippet: .. For overexpression of human CUX1 p200, |

